Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation

Volumn 49, Issue 4, 2014, Pages 553-560

  Sato, M ^a   Nakasone, H ^a   Terasako Saito, K ^a   Sakamoto, K ^a   Yamazaki, R ^a   Tanaka, Y ^a   Akahoshi, Y ^a   Nakano, H ^a   Ugai, T ^a   Wada, H ^a   Yamasaki, R ^a   Ishihara, Y ^a   Kawamura, K ^a   Ashizawa, M ^a   Kimura, S I ^a   Kikuchi, M ^a   Tanihara, A ^a   Kanda, J ^a   Kako, S ^a   Nishida, J ^a   Kanda, Y ^a   more..

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Allogeneic hematopoietic cell transplantation; Infectious events; Procalcitonin; Transplant related complications

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ACUTE KIDNEY FAILURE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANUS DISEASE; ARTICLE; BLOODSTREAM INFECTION; CATHETER INFECTION; CHOLECYSTITIS; COHORT ANALYSIS; CYSTITIS; EARLY DIAGNOSIS; ENGRAFTMENT SYNDROME; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; INFECTIOUS COMPLICATION; LUNG ALVEOLUS PROTEINOSIS; MAJOR CLINICAL STUDY; MALE; MOUTH INFECTION; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STRATIFIED SAMPLE; ALLOTRANSPLANTATION; BACTERIAL INFECTIONS; BLOOD; CRYOPRESERVATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE;

BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CRYOPRESERVATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 84897530021     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.217     Document Type: Article

References (21)

1. Sato M, Kako S, Oshima K, Sato K, Terasako K, Kimura S et al. Prediction of infectious events by high-sensitivity C-reactive protein level before undergoing chemotherapy for acute myeloid leukaemia. Scand J Infect Dis 2010; 42: 97-101.
2. Sato M, Nakasone H, Oshima K, Ishihara Y, Wada H, Sakamoto K et al. Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT. Bone Marrow Transplant 2013; 48: 698-702.
3. Schots R, Kaufman L, Van Riet I, Ben Othman T, De Waele M, Van Camp B et al. Proinflammatory cytokines and their role in the development of major transplantrelated complications in the early phase after allogeneic bone marrow transplantation. Leukemia 2003; 17: 1150-1156.
4. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39: 206-217.
5. Scirè CA, Cavagna L, Perotti C, Bruschi E, Caporali R, Montecucco C. Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. Clin Exp Rheumatol 2006; 24: 123-128.
6. Meynaar IA, Droog W, Batstra M, Vreede R, Herbrink P. In Critically Ill Patients, Serum Procalcitonin Is More Useful in Differentiating between Sepsis and SIRS than CRP, Il-6, or LBP. Crit Care Res Pract (e-pub ahead of print 15 May 2011; doi: 10.1155/2011/594645).
7. Lai CC, Tan CK, Chen SY, Wang CY, Liu WL, Hou CC et al. Diagnostic performance of procalcitonin for bacteremia in patients with bacterial infection at the emergency department. J Infect 2010; 61: 512-515.
8. Galetto-Lacour A, Zamora SA, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 2003; 112: 1054-1060.
9. Wunder C, Eichelbrönner O, Roewer N. Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res 2004; 53: 158-163.
10. Koya J, Nannya Y, Ichikawa M, Kurokawa M. The clinical role of procalcitonin in hematopoietic SCT. Bone Marrow Transplant 2012; 47: 1326-1331.
11. Mori Y, Miyawaki K, Kato K, Takenaka K, Iwasaki H, Harada N et al. Diagnostic value of serum procalcitonin and C-reactive protein for infections after allogeneic hematopoietic stem cell transplantation versus nontransplant setting. Intern Med 2011; 50: 2149-2155.
12. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
13. Oshima K, Takahashi T, Mori T, Matsuyama T, Usuki K, Asano-Mori Y et al. One-year low-dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group. Transpl Infect Dis 2010; 12: 421-427.
14. Kanda J, Saji H, Fukuda T, Kobayashi T, Miyamura K, Eto T et al. Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study. Blood 119: 2409-2416.
15. Nakai K, Kanda Y, Fukuhara S, Sakamaki H, Okamoto S, Kodera Y et al. Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome. Leukemia 2005; 19: 396-401.
16. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 2012; 48: 452-458.
17. Hausfater P, Garric S, Ayed SB, Rosenheim M, Bernard M, Riou B. Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis 2002; 34: 895-901.
18. Engel A, Steinbach G, Kern P, Kern WV. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis 1999; 31: 185-189.
19. Hambach L, Eder M, Dammann E, Schrauder A, Sykora KW, Dieterich C et al. Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation. Haematologica 2002; 87: 643-651.
20. Persson L, Engervall P, Magnuson A, Vikerfors T, Söderquist B, Hansson LO et al. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis 2004; 36: 365-371.
21. Van den Bruel A, Thompson MJ, Haj-Hassan T, Stevens R, Moll H, Lakhanpaul M et al. Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review. BMJ 2011; 342: d3082.